Pharmaceutical Technology

FEBRUARY 23, 2023

This collaboration is expected to help expedite the clinical manufacturing of RVM-V001 and future mRNA-based vaccines that target infectious diseases such as Clostriodioides difficile infection (CDI) and Respiratory syncytial virus (RSV). Topic sponsors are not involved in the creation of editorial content.

Vaccination 289

Vaccination Vaccine Gene Therapy Manufacturing 289

Sciensano

OCTOBER 10, 2023

The workshop was part of the UNITED4S urveillance project, which focuses on strengthening infectious disease surveillance. The aim is to be better prepared for a possible outbreak and to prevent the spread through animals or food and thus reduce the burden of disease in humans. ”

Scientist 64

Scientist 64

The Pharma Data

OCTOBER 27, 2020

Infectious Disease Least Severe in School-Aged Children. 27, 2020 — School-aged children seem to have the least severe disease for different infectious diseases, according to a study published online Oct. Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Immune Response 52

Immune Response Vaccination Vaccine Medicine 52

Roots Analysis

APRIL 5, 2023

However, it is important to note that, currently, the approved antiviral drugs (around 80) are capable of targeting only 10 of the 220 known viruses that are responsible for causing multiple life threatening infectious diseases in humans.

Drugs 52

Drugs Marketing Clinical Trials Clinical Trials 52

Pharmaceutical Technology

MAY 12, 2023

NYBC Ventures will focus on investment in therapeutics, devices and new technologies to address issues in benign haematology, transfusion medicine and infectious disease. Topic sponsors are not involved in the creation of editorial content. The New York Blood Center (NYBC) has provided the investment for the inaugural fund.

Gene Therapy 130

Gene Therapy Gene Life Science Manufacturing 130

Drug Discovery World

DECEMBER 22, 2022

Shelley McLendon , SVP of Vaccine and Infectious Diseases Program Management at ICON, attended the World Vaccine Congress Europe from 16-19 October 2022 in Barcelona, Spain. Since then, she has shared with DDW exclusive insights on the topic. . Disease surveillance and reporting .

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

Camargo

JUNE 9, 2021

Some of the more common ROAs used to perform toxicology studies include oral, intravenous, subcutaneous, inhalation , and topical delivery, but there are numerous more including intravesical, intravitreal, intrathecal, and intralymphatic. It is also useful in DART and pregnancy studies as well as in studying neurodegenerative diseases.

Reagent 178

Reagent Production Drugs Allergies 178

Drug Discovery World

DECEMBER 13, 2023

On Tuesday 6 February at 11.30am, attendees will hear on the topic ‘Structural vaccinology for influenza’ from Masaru Kanekiyo, Chief of Molecular Immunoengineering Section of the Vaccine Research Center (VRC) at the US National Institute of Allergy and Infectious Diseases (NIAID).

Allergies 52

Allergies Engineer Drugs Development 52

Sciensano

JULY 17, 2023

Type of press: Press release Associated health topics: Coronavirus Acute respiratory tract infection Published on: Thursday, July 20, 2023 Language English Submitted by Marinka Vangenck on Mon, 17/07/2023 - 15:01 cAncestors: 12064 305 12972 359 305 cDomains only: 305 305 Service: Epidemiology of infectious diseases

Nurses 40

Nurses 40

The Pharma Data

OCTOBER 21, 2020

the leading infectious disease expert in the United States, said on Wednesday he is “cautiously optimistic” that a COVID-19 vaccine will be ready by year’s end. National Institute of Allergy and Infectious Diseases, took pains to paint a realistic picture of the significant hurdles that lie ahead.

Vaccination 52

Vaccination Vaccine Allergies Trials 52

Sciensano

JANUARY 19, 2024

ITM and Sciensano call for action to slow down the establishment and spread of the tiger mosquito in Belgium, thus minimizing the risk of local transmission of potentially severe diseases. The active contribution of citizens is vital in this effort.

Medicine 88

Medicine 88

The Pharma Data

DECEMBER 21, 2020

director of the Center for Infectious Diseases Research at the Walter Reed Army Institute of Research. Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox. The new variant is rapidly spreading in parts of England, CNN reported. CNN Article. © 2020 HealthDay.

Research 52

Research Vaccination Vaccine Genetics 52

Drug Discovery World

JULY 8, 2022

GSK’s annual Palio meeting is taking place with a focus on how preventative approaches to disease can help mitigate climate change. . As climate change continues to worsen, this can impact respiratory health issues, increasing the spread of diseases such as malaria, and fostering antimicrobial resistance.

Vaccination 52

Vaccination Vaccine Allergies Bacteria 52

Drug Discovery World

JANUARY 22, 2024

Erin Welsh , PhD, is a disease ecologist and epidemiologist now working full-time as a science communicator. Erin Allmann Updyke, MD, PhD is an epidemiologist and disease ecologist currently in a medical residency programme to complete her training. Together, they make up This Podcast Will Kill You.

Scientist 64

Scientist Bacteria Drugs Research 64

VirTrial

FEBRUARY 28, 2024

Topic 1: Modular implementation in phase III, and meeting the needs of all stakeholders Even though we collect data remotely in multiple other therapeutic areas, oncology is not one where we routinely see this employed, so that brings with it the technologies, techniques, and methodologies for remote data collection.

Development 52

Development Drugs Trials Clinical Development 52

pharmaphorum

NOVEMBER 1, 2022

RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious, and chronic diseases. Further topics to be examined comprise of novel RNA modalities encompassing self-amplifying RNA, saRNA, circular RNA, lnc RNA and many more.

RNA 52

RNA Genetics Gene Editing In-Vitro 52

Sciensano

MAY 18, 2022

The objective of this project was to implement a multidisciplinary approach and create a network of experts in order to improve the surveillance of infectious diseases with the help of cutting-edge technologies, such as high-throughput sequencing. BE READY project. results_of_the_live_polling.pdf. BE READY project.

Genome 52

Genome Genomics Research 52

The Pharma Data

JANUARY 7, 2021

Centers for Disease Control and Prevention in Atlanta, and colleagues examined the proportion of SARS-CoV-2 transmissions in the community that likely occurred from asymptomatic individuals. Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox. THURSDAY, Jan. 7 in JAMA Network Open.

Development 52

Development Research 52

The Pharma Data

OCTOBER 22, 2020

Centers of Disease Control and Prevention, will likely have the biggest impact in group settings where people are in repeated contact with others for brief periods over the course of a day, such as schools and workplaces, The Washington Post reported. THURSDAY, Oct. The change, issued by the U.S. The Washington Post Article More Information.

52

52

The Pharma Data

JUNE 30, 2021

Karin Moestl remarks: “This topic is not only important to cat populations but also examines the potential epidemiological role of cats, which is of great importance from a One Health 1 perspective.”. This could allow clinicians to rapidly identify regressively infected cats that are unlikely to develop FeLV-related disease.

Scientist 52

Scientist Immune Response Antibody Development 52

pharmaphorum

FEBRUARY 24, 2021

Changes in the “Spike” protein targeted by nearly all the vaccines approved or in development could also lead to more infectious variants, such as the strain that emerged in Kent and is now prevalent across most of the UK.

Vaccination 58

Vaccination Vaccine Immune Response Regulation 58

The Pharma Data

OCTOBER 27, 2020

National Institute of Allergy and Infectious Diseases, which sponsored the Lilly study, pulled the plug on the trial Monday — not because of any safety problem, but because there was only a slight chance that the drug would be effective. TUESDAY, Oct. But the U.S. AP News Article 1 AP News Article 2. © 2020 HealthDay.

Antibody 52

Antibody Trials Drugs Allergies 52

The Pharma Data

DECEMBER 17, 2020

The Moderna vaccine was developed in partnership with the National Institute of Allergy and Infectious Diseases, with a government investment of $4.1 Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox. More Information. Washington Post Article. © 2020 HealthDay. .

Vaccination 52

Vaccination Vaccine Allergies Clinical Trials 52

The Pharma Data

FEBRUARY 13, 2022

FDA a ccepts Dupixent ® (dupilumab) for Priority Review in c hildren a ged 6 m onths to 5 y ears with m oderate-to-severe a topic d ermatitis. Atopic dermatitis is a chronic type 2 inflammatory skin disease, and 85 to 90% of patients develop symptoms (onset of disease) before 5 years of age, which can often continue through adulthood.

Medicine 40

Medicine Genetics Antibody Allergies 40

Camargo

JUNE 4, 2021

Since this new product is applied via instillation, Heron bridged from the topically applied product to the systemic data in the public literature. Qualified Infectious Disease Product Designation—Questions and Answers. The guidance covers several topics: Established Conditions. Pharmaceutical Quality System.

Development 130

Development Production Drugs Marketing 130

Sciensano

MAY 15, 2023

The website also provides information on the mosquito’s characteristics, breeding sites, biting behaviour, diseases it can transmit, and tips to prevent mosquito bites and breeding sites. A map with the results of the notifications is also available on the website. or +32 2 642 54 20 ITM for active surveillance: adams@itg.be

Medicine 52

Medicine Research 52

Drug Discovery World

OCTOBER 13, 2022

The turn-out for the Tech Theatre was rewarding for the DDW team as well as the experts who presented, as the relevance of the topics covered was made clear. This was one of a varied range of keynote presentations covering a diverse range of drug discovery topics. . Presentations . Read more on the programme here.

Drugs 52

Drugs In-Vivo In-Vitro Biobanking 52

XTalks

MAY 2, 2022

The featured speaker will discuss this topic with both patients and industry leaders. RVVC is defined by the Centers for Disease Control and Prevention (CDC) as the occurrence of three or more symptomatic acute yeast infections in a span of 12 months. “We Related: Singer Mary J.

FDA Approval 98

FDA Approval Drugs Clinical Trials Clinical Trials 98

The Pharma Data

JANUARY 27, 2021

New and more infectious coronavirus variants are beginning to appear in the United States, but all have remained vulnerable to the two vaccines now being distributed to Americans. Centers for Disease Control and Prevention. Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Nurses 52

Nurses Doctors Doctor Vaccination 52

The Pharma Data

JANUARY 26, 2021

case of a more infectious Brazilian variant of the coronavirus has been confirmed in a person in Minnesota who recently traveled to Brazil, state health officials said Monday. Centers for Disease Control and Prevention. Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Containment 52

Containment Antibody Scientist Research 52

The Pharma Data

JANUARY 14, 2021

Centers for Disease Control and Prevention reported Wednesday. Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox. THURSDAY, Jan. Close to a million doses — more than 951,000, to be more exact — made their way into the arms of Americans in the past 24 hours, the U.S.

Vaccination 52

Vaccination Vaccine Gene Scientist 52

Pharmaceutical Technology

JANUARY 20, 2023

This program aims to bring collaboration with researchers to develop novel mRNA treatments for “emerging and neglected infectious diseases ”. Topic sponsors are not involved in the creation of editorial content. We know that outbreaks will happen. Cell & Gene Therapy coverage on Clinical Trials Arena is supported by Cytiva.

Manufacturing 246

Manufacturing Vaccination Vaccine Gene Therapy 246

The Pharma Data

MAY 31, 2022

if approved Acceptance marks another important step in advancing Dupixent for a broad range of diseases with underlying type 2 inflammation. Both trials met the primary and key secondary endpoints, showing Dupixent significantly improved disease signs and symptoms compared to placebo, including reduction in itch and skin lesions.

Genetics 52

Genetics Antibody Medicine Trials 52

XTalks

FEBRUARY 19, 2024

In a recent study published by Weill Cornell Medicine in the Journal of Infectious Diseases , researchers have reported the potential of Moderna’s experimental mRNA vaccine in protecting adults against CMV, which could potentially also stop the transmission of the virus from mothers to their infants during pregnancy.

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

The Pharma Data

NOVEMBER 20, 2020

.” The FDA granted the EUA based on data from the ACTT-2 trial, a randomized, double-blind, placebo-controlled clinical trial conducted by the National Institute of Allergy and Infectious Diseases. Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox. More Information.

Allergies 52

Allergies FDA Approval Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 16, 2020

National Institute of Allergy and Infectious Diseases. Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox. Moderna, based in Cambridge, Massachusetts, developed its vaccine in collaboration with researchers from the Vaccine Research Center, part of the U.S. More Information.

Vaccination 52

Vaccination Vaccine Allergies Research 52

The Pharma Data

OCTOBER 29, 2020

29, 2020 — America’s leading infectious disease expert called for a national mask mandate on Wednesday as COVID-19 cases surged across the country. Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox. Professional. Fauci Calls for National Mask Mandate.

52

52